Evidence map›Paper›PMID 22750217›Full record

ArticleHeart rhythm2012

Intracardiac J-point elevation before the onset of polymorphic ventricular tachycardia and ventricular fibrillation in patients with an implantable cardioverter-defibrillator.

Larisa G Tereshchenko, Aaron McCabe, Lichy Han, Sanjoli Sur, Timothy Huang, Joseph E Marine, Alan Cheng, David D Spragg, Sunil Sinha, Hugh Calkins and 3 more

Registry-linked trialAbstract read
In one paragraph

Article in Heart rhythm, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00916435 (Prospective Observational Study of the ICD Intracardiac Electrograms for Prediction of Ventricular Tachyarrhythmias and Congestive Heart Failure), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00916435 completednot on this map

Prospective Observational Study of the ICD Intracardiac Electrograms for Prediction of Ventricular Tachyarrhythmias and Congestive Heart Failure

TypeobservationalSponsorJohns Hopkins UniversityRan2005 to 2011Enrolled630ConditionsCongestive Heart Failure, Sudden Cardiac Death, Arrhythmia, Cardiomyopathies
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Larisa G TereshchenkoDivision of Cardiology, Department of Medicine, Johns Hopkins Hospital, 600 N Wolfe St., Baltimore, MD 21287, USA. lteresh1@jhmi.edu
Aaron McCabe
Lichy Han
Sanjoli Sur
Timothy Huang
Joseph E Marine
Alan Cheng
David D Spragg
Sunil Sinha
Hugh Calkins
Kenneth Stein
Gordon F Tomaselli
Ronald D Berger

Funding

Fundamental Biology of SCD and its Application to Identify Patients at RiskR01HL091062 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI TOMASELLI, GORDON FRANK · 2009 to 2013
$3.4M
NHLBI NIH HHS HL R01 091062NHLBI NIH HHS R01 HL091062
6 · The paper itself

Abstract

backgroundThe clinical importance of the J-point elevation on electrocardiogram is controversial.

objectiveTo study intracardiac J-point amplitude before ventricular arrhythmia.

methodsBaseline 12-lead electrocardiogram and far-field right ventricular intracardiac implantable cardioverter-defibrillator electrograms were recorded at rest in 494 patients (mean age 60.4 ± 13.1 years; 360 [72.9%] men) with structural heart disease (278 [56.3%] ischemic cardiomyopathy) who received primary (463 [93.9%] patients) or secondary prevention implantable cardioverter-defibrillator. Ten-second intracardiac far-field electrograms before the onset of arrhythmia were compared with the baseline. The J-point amplitude was measured on the baseline 12-lead surface electrocardiogram and the intracardiac far-field electrogram. The relative J-point amplitude was calculated as the ratio of J-point amplitude to peak-to-peak R-wave.

resultsThe paired t test showed that the relative intracardiac J-point amplitude was significantly higher before polymorphic ventricular tachycardia/ventricular fibrillation (VF) onset (0.28 ± 0.08 vs -0.19 ± 0.39; P = .012) than at baseline. In a mixed-effects logistic regression model, adjusted for multiple episodes per patient, each 10% increase in relative J-point amplitude increased the odds of having ventricular tachycardia/VF by 13% (odds ratio 1.13 [95% confidence interval 1.07-1.19]; P < .0001) and increased the odds of having polymorphic ventricular tachycardia/VF by 27% (odds ratio 1.27 [95% confidence interval 1.11-1.46]; P = .001).

conclusionsThe relative intracardiac J-point amplitude is augmented immediately before the onset of polymorphic ventricular tachycardia/VF in patients with structural heart disease.

Indexed as

Defibrillators, ImplantableChi-Square DistributionElectrocardiographyFemaleHeart Conduction SystemHumansLinear ModelsMaleMiddle AgedProspective StudiesTachycardia, VentricularVentricular Fibrillation

Identifiers

PMID22750217
PMCPMC3459168

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.